CLXT
Calyxt Inc
Price:  
6.30 
USD
Volume:  
254,637.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLXT WACC - Weighted Average Cost of Capital

The WACC of Calyxt Inc (CLXT) is 7.3%.

The Cost of Equity of Calyxt Inc (CLXT) is 7.35%.
The Cost of Debt of Calyxt Inc (CLXT) is 5.50%.

Range Selected
Cost of equity 6.40% - 8.30% 7.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.4% - 8.3% 7.3%
WACC

CLXT WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.44 0.52
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 8.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 4.00% 7.00%
After-tax WACC 6.4% 8.3%
Selected WACC 7.3%

CLXT's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CLXT:

cost_of_equity (7.35%) = risk_free_rate (4.45%) + equity_risk_premium (5.50%) * adjusted_beta (0.44) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.